Store in a cool, dry and dark place. Protect from light and moisture.
Prescription/Non prescription
Prescription
Usage/Application
Used to treat bacterial infections in your body
Country of Origin
Made in India
Availability
In Stock
Long serum elimination half (t½) 3 to 4 hours. Compare with 0.5 hourse for cefaclor and 1.5 hours for cephalexin Powerful third generation spectrum cephalosporin particularly active against many enterobacteriaceae. Haemophiles influenza, streptococcus pyogenes and branhamella catarrhalis. INDICATIONS:- Upper and lower respiratory tract infections Acute otitis media Tonsillitis and pharyngitis Community - acquired pneumonia Acute bacterial exacerbation of chronic bronchitis Actue maxillary sinusitis
Find products similar to Linkpod-200 Tablets, 100 Mg
Interested in this product?Get Latest Price from the seller
About the Company
GST Registration Date
01-07-2017
Legal Status of Firm
Limited Company
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
51 To 100 People
Annual Turnover
5 - 25 Cr
IndiaMART Member Since
June 2017
GST
24AAKCM7390Q1ZM
Makronix is a All Together Truly Indian Pharmaceutical Company, poised to achieve outstanding market presence in area of operation, offering specialty products and delivery systems of world class quality, to achieve the motto of Approaching Heights for Maximal Health Care.
The Architects of Makronix are a team comprising of young Pharma technocrats, management professionals and energetic marketing professionals who bring to the company a new Vision and with totally young & enthusiastic board of directors it intends to be a global pharmaceutical company. With total dedication towards maximal health care, company shall be able to make greater contribution to the health quality of life of the ailing humanity around the globe.
Makronix is focused on increasing the momentum in the ethical business in its key markets through organic and inorganic growth routes. It continues to evaluate acquisition opportunities in India, emerging and developed markets to accentuate its business and competitiveness. The company's growth is well spread across geographies with near equal focus on developed and emerging markets. Makronix has entered into specialty therapeutic segments like Cardio -diabetics, Nootropics. Neuropathy pain management. These new growth areas will add significant depth to its existing product pipeline. Disclaimer: No drug is sold without a valid prescription
